AU8546591A - Non-aqueous liquid oral suspensions - Google Patents

Non-aqueous liquid oral suspensions

Info

Publication number
AU8546591A
AU8546591A AU85465/91A AU8546591A AU8546591A AU 8546591 A AU8546591 A AU 8546591A AU 85465/91 A AU85465/91 A AU 85465/91A AU 8546591 A AU8546591 A AU 8546591A AU 8546591 A AU8546591 A AU 8546591A
Authority
AU
Australia
Prior art keywords
aqueous liquid
liquid oral
oral suspensions
suspensions
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85465/91A
Inventor
Malcolm Foreman
Harvey Lee Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU8546591A publication Critical patent/AU8546591A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU85465/91A 1990-09-13 1991-09-10 Non-aqueous liquid oral suspensions Abandoned AU8546591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58186690A 1990-09-13 1990-09-13
US581866 1990-09-13

Publications (1)

Publication Number Publication Date
AU8546591A true AU8546591A (en) 1992-04-15

Family

ID=24326890

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85465/91A Abandoned AU8546591A (en) 1990-09-13 1991-09-10 Non-aqueous liquid oral suspensions

Country Status (7)

Country Link
EP (1) EP0548238A1 (en)
JP (1) JPH06501003A (en)
AU (1) AU8546591A (en)
NZ (1) NZ239784A (en)
PT (1) PT98975A (en)
WO (1) WO1992004893A1 (en)
ZA (1) ZA917310B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476447A (en) * 1968-03-28 1969-11-04 Westinghouse Electric Corp Self-aligning hydrostatic bearing
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
US5484800A (en) * 1994-08-30 1996-01-16 American Home Products Corporation Lipid-based liquid medicinal composition
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
AU7468096A (en) * 1995-10-30 1997-05-22 Warner-Lambert Company Enhanced anti-inflammatory oral composition containing h2 receptor antagonist and antimicrobial oils
ES2153786B1 (en) * 1999-06-10 2001-10-16 S A L V A T Lab Sa LIQUID PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF AMARGE AND SUSCEPTIBLE ACTIVE HYDROLYSIS PRINCIPLES.
DK2319301T3 (en) 2001-11-30 2017-12-04 Amgen Fremont Inc Transgenic animals with human Ig lambda light chain genes
AU2003249904A1 (en) * 2002-07-02 2004-01-23 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20040202696A1 (en) * 2003-04-14 2004-10-14 Cts Chemical Industries Ltd. Administration form for veterinary use
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
ES2423929T3 (en) * 2007-02-16 2013-09-25 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition containing fine particle oil based suspension
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
JP2013504610A (en) * 2009-09-16 2013-02-07 ノヴォ ノルディスク アー／エス Stable non-aqueous liquid pharmaceutical composition comprising insulin
WO2013153000A2 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
GB2529605B (en) * 2014-06-03 2018-03-21 Essential Pharmaceuticals Ltd Pharmaceutical composition
BR102015024165A2 (en) * 2015-09-18 2017-03-28 Prati Donaduzzi & Cia Ltda oral pharmaceutical composition comprising cannabinoid, process for its preparation and use
HUE055231T2 (en) 2016-12-16 2021-11-29 Novo Nordisk As Insulin containing pharmaceutical compositions
EP3784214A4 (en) * 2018-04-27 2022-01-19 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0684420B2 (en) * 1986-12-26 1994-10-26 三菱レイヨン株式会社 Active energy ray curable resin composition
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions

Also Published As

Publication number Publication date
NZ239784A (en) 1994-05-26
PT98975A (en) 1992-07-31
ZA917310B (en) 1992-10-28
JPH06501003A (en) 1994-01-27
EP0548238A1 (en) 1993-06-30
WO1992004893A1 (en) 1992-04-02

Similar Documents

Publication Publication Date Title
AU639126B2 (en) Oxorapamycin
AU614482B3 (en) Receptacle
AU6299790A (en) Container
AU8536291A (en) Liquid/liquid hydrocyclone
AU8546591A (en) Non-aqueous liquid oral suspensions
AU8791591A (en) Tnf-muteins
AU626649B2 (en) Oral medication in the form of non-aqueous suspensions
AU7846991A (en) Aminobenzodiazepines
AU7956191A (en) Transportsystem
AU7804691A (en) N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas
AU7726391A (en) Slitterscorer
AU617287B3 (en) Receptacle
AU6426290A (en) Container
AU4930490A (en) Can end
AU7566691A (en) Compostor
AU8740291A (en) 3d-spectacles
AU8200491A (en) Facilitating endoscopy
AU7587991A (en) Electrodermatome
AU5791490A (en) Container
AU8920091A (en) Container structure
AU8984191A (en) Thiadiazinones
AU8657991A (en) Hand-saws
AU664878B2 (en) An improved container
AU8675791A (en) Container
AU8669591A (en) Container